SCHEMBL6935868

SCHEMBL6935868

CNCCOCCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16379700 1.00 KDM4E (0.37)
SCHEMBL16806579 1.00 KDM4E (0.37)
SCHEMBL27333126 1.00 KDM4E (0.37)
SCHEMBL39815 1.00 KDM4E (0.37)
SCHEMBL7901114 1.00 KDM4E (0.37)
SCHEMBL19202513 1.00 KDM4E (0.37)
SCHEMBL15984875 1.00 KDM4E (0.37)
SCHEMBL17243850 1.00 KDM4E (0.37)
SCHEMBL21876827 1.00 KDM4E (0.37)
Bromide SCHEMBL23217987 0.97 KDM4E (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720196-A1 PURPURIN ANALOGS FOR USE IN PHOTODYNAMIC THERAPY RMW Cho Group Limited (HK) 2026-04-08 EP disclosed
EP-4656629-A1 INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE MitoImmune Therapeutics Inc. (KR) 2025-12-03 EP disclosed
WO-2024246550-A1 PURPURIN ANALOGS FOR USE IN PHOTODYNAMIC THERAPY RMW CHO GROUP LIMITED (CN) 2024-12-05 WO disclosed
EP-3604305-B1 NOVEL PYRIDONE CARBOXYLIC ACID DERIVATIVE OR SALT THEREOF WAKUNAGA PHARMA CO LTD (JP) 2024-08-28 EP disclosed
WO-2024158205-A1 INDOLE DERIVATIVE WITH SUBSTITUENT AND PHARMACEUTICAL USE 주식회사 미토이뮨테라퓨틱스 2024-08-02 WO disclosed
WO-2024080872-A1 STRAINED BICYCLONONENES TAGWORKS PHARMACEUTICALS B.V. (NL) 2024-04-18 WO disclosed
US-20240067651-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. 2024-02-29 US disclosed
EP-4328310-A1 SIRNA TARGETING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2024-02-28 EP disclosed
US-20230359119-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-09 US disclosed
EP-4272825-A2 MTORC MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-11-08 EP disclosed
US-6187955-B1 A MOISTURIZER FOR SOFTENING SKINS; USEFUL AS COMPONENTS OF COSMETIC FORMULATIONS KAO CORPORATION (JP) 2001-02-13 US disclosed
EP-0425571-B2 NOVEL MAGNETIC RESONANCE IMAGING AGENTS MALLINCKRODT MEDICAL INC (US) 2000-09-20 EP disclosed
EP-0856539-A1 Cross-linked polymer Mitsui Chemicals, Inc. (JP) 1998-08-05 EP disclosed
US-5723133-A GUANIDINE WITH ORGANIC ACID FOR SKIN SOFTENING KAO CORPORATION (JP) 1998-03-03 US disclosed
EP-0805674-A1 SKIN AND HAIR COSMETIC COMPOSITIONS Kao Corporation (JP) 1997-11-12 EP disclosed
WO-1997014401-A1 SKIN AND HAIR COSMETIC COMPOSITIONS KAO CORPORATION (JP) 1997-04-24 WO disclosed
EP-0425571-B1 NOVEL MAGNETIC RESONANCE IMAGING AGENTS MALLINCKRODT INC (US) 1996-09-11 EP disclosed
US-5137711-A PARAMAGNETIC DTPA AND EDTA ALKOXYALKYLAMIDE COMPLEXES AS MRI AGENTS MALLICKRODT MEDICAL, INC. (US) 1992-08-11 US disclosed
EP-0425571-A1 NOVEL MAGNETIC RESONANCE IMAGING AGENTS. MALLINCKRODT INC (US) 1991-05-08 EP disclosed
WO-1990001024-A1 NOVEL MAGNETIC RESONANCE IMAGING AGENTS MALLINCKRODT, INC. (US) 1990-02-08 WO disclosed